drugset / Trial / NCT06043908

The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye

NCT06043908

Phase 4 Unknown 60 enrolled Peking University Third Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to observe the effect of 0.05% cyclosporine eyedrops combined with artificial tears in patients with dry eyes after corneal refractive surgery and to observe the changes in ocular surface characteristics and tear inflammatory cytokines before and after treatment.

Timeline

Start
2022-08-31
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide 0.05 % Topical

Indications